General MedicationsINJECTIONGeneric
TRASYLOL
APROTININ
Standard Dose
10,000KIU/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview TRASYLOL is listed in Drugs@FDA under application 020304 (BLA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient APROTININ Form and strength INJECTABLE;INJECTION - 10,000KIU/ML Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2006-12-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRASYLOL is listed in Drugs@FDA under application 020304 (BLA). Review priority: STANDARD Marketing status: Discontinued Active ingredient APROTININ Form and strength INJECTABLE;INJECTION - 10,000KIU/ML Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2006-12-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.